Radiation may force Boehringer to close plant

Boehringer Ingelheim may have to abandon a plant largely unscathed by last month's Japan earthquake and tsunami, as engineers struggle to contain radiation spewing from a crippled nuclear plant. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.